Measurement of damage in 210 Mexican patients with systemic lupus erythematosus: relationship with disease duration

被引:81
作者
Zonana-Nacach, A [1 ]
Camargo-Coronel, A [1 ]
Yanez, P [1 ]
de Lourdes Sanchez, M [1 ]
Jimenez-Balderas, FJ [1 ]
Aceves-Avila, J [1 ]
Martinez-Osuna, P [1 ]
Fuentes, J [1 ]
Medina, F [1 ]
Fraga, A [1 ]
机构
[1] Inst Mexicano Seguro Social, Hosp Especialidades Ctr Med Nacl, Dept Rheumatol, Mexico City 06720, DF, Mexico
关键词
SLE; damage; disease course; prognosis; outcome;
D O I
10.1191/096120398678919831
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index is a validated instrument specifically designed to ascertain damage in SLE; this instrument has been applied mainly to Caucasians and African-American SLE patients. The objective of this study was to assess damage using the SLICC/ACR Damage Index in Mexican SLE patients. The SLICC/ACR Damage Index was applied to 210 consecutive SLE patients with disease of variable duration. The SLICC/ACR Damage Index was assessed by review of hospital clinical records, interview and physical examination. One hundred and seventeen (55.5%) patients had some damage. The proportion of patients with damage increased significantly with disease duration (33% at 1-60 months, 66% at 61-120 months and 70% at greater than or equal to 121 months, P < 0.001). The main organ systems involved were musculoskeletal (osteonecrosis), neuropsychiatric (neuropathy, seizures), gonadal (amenorrhea prior to age 40 years), ocular (cataracts), renal (glomerular filtration <50%) and peripheral vascular (permanent damage by venous thrombosis). Damage was frequent, increased over time, particularly for ocular, renal, musculoskeletal and gonadal. Patients who experienced damage were older, had a longer disease duration, a greater number of ACR criteria at diagnosis, and were more likely to have renal involvement and antibodies to dsDNA. The damage occurred in many different domains and started to develop early after disease onset. Mexican patients had more peripheral vascular and gonadal involvement compared with published data from non-Hispanic SLE populations.
引用
收藏
页码:119 / 123
页数:5
相关论文
共 32 条
  • [1] PROGNOSTIC FACTORS IN LUPUS NEPHRITIS - CONTRIBUTION OF RENAL HISTOLOGIC DATA
    AUSTIN, HA
    MUENZ, LR
    JOYCE, KM
    ANTONOVYCH, TA
    KULLICK, ME
    KLIPPEL, JH
    DECKER, JL
    BALOW, JE
    [J]. AMERICAN JOURNAL OF MEDICINE, 1983, 75 (03) : 382 - 391
  • [2] CLINICAL-FEATURES OF SYSTEMIC LUPUS-ERYTHEMATOSUS - DIFFERENCES RELATED TO RACE AND AGE OF ONSET
    BALLOU, SP
    KHAN, MA
    KUSHNER, I
    [J]. ARTHRITIS AND RHEUMATISM, 1982, 25 (01): : 55 - 60
  • [3] RISK FOR SUSTAINED AMENORRHEA IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS RECEIVING INTERMITTENT PULSE CYCLOPHOSPHAMIDE THERAPY
    BOUMPAS, DT
    AUSTIN, HA
    VAUGHAN, EM
    YARBORO, CH
    KLIPPEL, JH
    BALOW, JE
    [J]. ANNALS OF INTERNAL MEDICINE, 1993, 119 (05) : 366 - 369
  • [4] Cumulative rate of relapse of lupus nephritis after successful treatment with cyclophosphamide
    Ciruelo, E
    delaCruz, J
    Lopez, I
    GomezReino, JJ
    [J]. ARTHRITIS AND RHEUMATISM, 1996, 39 (12): : 2028 - 2034
  • [5] AVASCULAR (ASEPTIC) BONE NECROSIS ASSOCIATED WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    DUBOIS, EL
    COZEN, L
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1960, 174 (08): : 966 - 971
  • [6] THE TIME-DEPENDENCE OF LONG-TERM PREDICTION IN LUPUS NEPHRITIS
    ESDAILE, JM
    ABRAHAMOWICZ, M
    MACKENZIE, T
    HAYSLETT, JP
    KASHGARIAN, M
    [J]. ARTHRITIS AND RHEUMATISM, 1994, 37 (03): : 359 - 368
  • [7] SYSTEMIC LUPUS-ERYTHEMATOSUS IN COMMUNITY - INCIDENCE, PREVALENCE, OUTCOME, AND FIRST SYMPTOMS - HIGH PREVALENCE IN BLACK WOMEN
    FESSEL, WJ
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1974, 134 (06) : 1027 - 1035
  • [8] GINZLER EM, 1993, J RHEUMATOL, V20, P1694
  • [9] A MULTI-CENTER STUDY OF OUTCOME IN SYSTEMIC LUPUS-ERYTHEMATOSUS .1. ENTRY VARIABLES AS PREDICTORS OF PROGNOSIS
    GINZLER, EM
    DIAMOND, HS
    WEINER, M
    SCHLESINGER, M
    FRIES, JF
    WASNER, C
    MEDSGER, TA
    ZIEGLER, G
    KLIPPEL, JH
    HADLER, NM
    ALBERT, DA
    HESS, EV
    SPENCERGREEN, G
    GRAYZEL, A
    WORTH, D
    HAHN, BH
    BARNETT, EV
    [J]. ARTHRITIS AND RHEUMATISM, 1982, 25 (06): : 601 - 611
  • [10] The development and initial validation of the systemic lupus international collaborating clinics American College of Rheumatology Damage Index for Systemic Lupus Erythematosus
    Gladman, D
    Ginzler, E
    Goldsmith, C
    Fortin, P
    Liang, M
    Urowitz, M
    Bacon, P
    Bombardieri, S
    Hanly, J
    Hay, E
    Isenberg, D
    Jones, J
    Kalunian, K
    Maddison, P
    Nived, O
    Petri, M
    Richter, M
    SanchezGuerrero, J
    Snaith, M
    Sturfelt, G
    Symmons, D
    Zoma, A
    [J]. ARTHRITIS AND RHEUMATISM, 1996, 39 (03): : 363 - 369